474 related articles for article (PubMed ID: 7542023)
1. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis.
Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A
BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
[TBL] [Abstract][Full Text] [Related]
4. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B
Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980
[TBL] [Abstract][Full Text] [Related]
5. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R
Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697
[TBL] [Abstract][Full Text] [Related]
6. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
[TBL] [Abstract][Full Text] [Related]
7. Anomalies fœtales affectant le tube neural : Dépistage / diagnostic prénatal et prise en charge de la grossesse.
Wilson RD
J Obstet Gynaecol Can; 2016 Dec; 38(12S):S496-S511. PubMed ID: 28063560
[No Abstract] [Full Text] [Related]
8. The limitation of referral level fetal ultrasound examination in the detection of spina bifida in Western Australia, 1990-1991.
Walpole IR; Phillips J; Pemberton PJ; Bower C; Goldblatt J
Med J Aust; 1993 Oct; 159(7):441-4. PubMed ID: 7692226
[TBL] [Abstract][Full Text] [Related]
9. Trends in neural tube defects 1980-1989.
Bower C; Raymond M; Lumley J; Bury G
Med J Aust; 1993 Feb; 158(3):152-4. PubMed ID: 8450777
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
Cuckle HS; Wald NJ; Cuckle PM
Prenat Diagn; 1989 Jun; 9(6):393-400. PubMed ID: 2668917
[TBL] [Abstract][Full Text] [Related]
11. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB
Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332
[TBL] [Abstract][Full Text] [Related]
12. Screening for Open Neural Tube Defects.
Krantz DA; Hallahan TW; Carmichael JB
Clin Lab Med; 2016 Jun; 36(2):401-6. PubMed ID: 27235920
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Cuckle H; Wald N; Stevenson JD; May HM; Ferguson-Smith MA; Ward AM; Barbour HM; Laurence KM; Norgaard-Pedersen B
Prenat Diagn; 1990 Feb; 10(2):71-7. PubMed ID: 1692997
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum alpha-fetoprotein and previous neural tube defects.
Wald N; Barker S; Peto R; Brock DJ; Bonnar J
Br J Obstet Gynaecol; 1976 Mar; 83(3):213-6. PubMed ID: 56196
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
Wald N; Cuckle H; Nanchahal K
Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of a serum screening service for neural-tube defects: the South Wales experience.
Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M
Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal alpha fetoprotein screening for defects in the neural tube].
Grob PJ
Schweiz Med Wochenschr; 1978 Aug; 108(34):1302-7. PubMed ID: 80821
[TBL] [Abstract][Full Text] [Related]
18. Antenatal screening in Oxford for fetal neural tube defects.
Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ
Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462
[TBL] [Abstract][Full Text] [Related]
19. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
Am J Obstet Gynecol; 1999 May; 180(5):1227-33. PubMed ID: 10329882
[TBL] [Abstract][Full Text] [Related]
20. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
